Skip to content
lsd.com

Academic or other sponsor

Icahn School of Medicine at Mount Sinai

12 registered trials on this registry, 4 recruiting now. An academic sponsor is usually answering a scientific question rather than seeking approval, which changes what its trials are designed to show.

12
Registered trials
4
Recruiting
1
In Phase 3
5
With results posted

Working on

Substances

Trials

All 12 trials

TrialStatusPhaseSubstanceSites
Neural Circuit Effects of Ketamine in DepressionNCT06213324 · Icahn School of Medicine at Mount SinaiRecruitingPhase 4ketamine1
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of DepressionNCT06559826 · Icahn School of Medicine at Mount SinaiRecruitingPhase 2ketamine1
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive DisorderNCT06592833 · Icahn School of Medicine at Mount SinaiRecruitingPhase 2psilocybin1
MDMA Assisted Therapy for BNNCT07542145 · Icahn School of Medicine at Mount SinaiRecruitingPhase 1mdma1
Treatment Study of Bipolar DepressionNCT00947791 · Icahn School of Medicine at Mount SinaiTerminatedPhase 4ketamine1
Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)NCT02397889 · Icahn School of Medicine at Mount SinaiCompletedPhase 2 / Phase 3ketamine1
Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive ImpairmentNCT06069843 · Icahn School of Medicine at Mount SinaiActive, not recruitingPhase 2ketamine1
Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSDNCT04889664 · Icahn School of Medicine at Mount SinaiCompletedPhase 2ketamine1
Intramuscular Ketamine for Suicidal IdeationNCT05105061 · Icahn School of Medicine at Mount SinaiWithdrawnPhase 2ketamine1
Ketamine and Nitroprusside for DepressionNCT03102736 · Icahn School of Medicine at Mount SinaiCompletedPhase 2ketamine1
Ketamine Plus Lithium in Treatment-Resistant DepressionNCT01880593 · Icahn School of Medicine at Mount SinaiCompletedPhase 2ketamine1
MRI Studies of Emotion in DepressionNCT02429011 · Icahn School of Medicine at Mount SinaiCompletedN/Aketamine1

Sponsor attribution is the lead sponsor recorded on ClinicalTrials.gov API v2. Collaborators are not counted here. Data build 2026-08-25.